Company: ACBM
Filing Date: 2025-07-23
Form Type: 10-Q
Source: 0001640334-25-001281
Chunk: 0

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-23
Form: 10-Q
Item: Item 1
Chunk 0
---
ACRO BIOMEDICAL CO., LTD.

Balance Sheets

(Unaudited)

  September 30,  December 31,   2024  2023        ASSETS      Current Assets      Cash $701  $376 Prepaid expenses  -   1,250 Total Current Assets  701   1,626          Operating lease right of use asset  33,375   52,233 Security deposit  4,600   4,600 TOTAL ASSETS $38,676  $58,459          LIABILITIES AND STOCKHOLDERS' DEFICIT                 Current Liabilities        Accounts payable and accrued expenses $155,507  $154,444 Deferred revenue  20,000   20,000 Due to related parties  115,298   88,796 Operating lease liabilities - current  26,499   25,335 Total Current Liabilities  317,304   288,575          Operating lease liabilities - noncurrent  6,876   26,898 TOTAL LIABILITIES  324,180   315,473          Stockholders' Deficit        Preferred stock: 25,000,000 authorized; $0.001 par value; no shares issued and outstanding  -   - Common stock: 100,000,000 authorized; $0.001 par value; 60,042,000 shares issued and outstanding  60,042   60,042 Additional paid-in capital  32,301,576   32,298,442 Accumulated deficit  (32,647,122)  (32,615,498)Total Stockholders’ Deficit  (285,504)  (257,014)         TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $38,676  $58,459 

The accompanying notes are an integral part of these unaudited financial statements.

 4Table of Contents

ACRO BIOMEDICAL CO., LTD.

Statements of Operations

(Unaudited)

  Three Months Ended   Nine Months Ended   September 30,  September 30,   2024  2023  2024  2023              Revenues